Page All:
Page 1
Mylan Launches First Ever App of Its Generic Brand Reference® Guide
- Convenient, up-to-date print edition also available -
PITTSBURGH, Sept. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched the first ever app of its Generic Brand Reference(®) (GBR) Guide, a free reference and educational tool that helps U.S. health care professionals, patients and pharmacy students to quickly identify the generic name for a brand product and vice versa. Earlier in the year, the company made available the 2012 print edition of its GBR in a convenient, pocket-sized format. Like the print edition, the app - for iPhone(®), iPod(®) touch and iPad(® *) - provides an easy-to-use cross-reference guide for brand and generic product names, and in addition offers clinical support tools, including laboratory reference values, an interactive medical abbreviations converter, and functional calculators for common systems of weights and measures.
Mylan North America President Tony Mauro said: "We are pleased to offer Mylan's 2012 GBR to health care professionals in the U.S., including pharmacists, physicians and nurses, and chain and wholesale buyers. The GBR provides a comprehensive and up-to-date list of the generic and brand names for more than 2,000 separate oral and liquid dosage forms, as well as injectable and transdermal products. Mylan is committed to partnering with health care providers to optimize their time and together expand access to high quality medicine."
Mylan's printed GBR includes product portfolio sections under the Mylan Pharmaceuticals, Mylan Institutional and Mylan Specialty names and provides an easy-to-navigate, alphabetized reference source for many health care providers working in one space. The app offers all of the convenience of the printed edition on a mobile device, including content that is updated to keep the dataset current, a smart search function, easy navigation and interactive clinical support tools.
To request a free printed copy of Mylan's 2012 GBR, visit mylanpharms.com. To download Mylan's free GBR app, visit the App Store(sm**) from any iOS-supported device, including the iPhone, iPod touch and iPad.
Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com.
* iPhone, iPod touch, and iPad( )are registered trademarks of Apple Inc.
** App Store is the service mark of Apple Inc.
SOURCE Mylan Inc.
Mylan Inc.
CONTACT: Nina Devlin (Media), +1 724.514.1968; Kris King (Investors), +1 724.514.1813
Web Site: http://www.mylan.com
Mylan Launches First Ever App of Its Generic Brand Reference® Guide
- Convenient, up-to-date print edition also available -
PITTSBURGH, Sept. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched the first ever app of its Generic Brand Reference(®) (GBR) Guide, a free reference and educational tool that helps U.S. health care professionals, patients and pharmacy students to quickly identify the generic name for a brand product and vice versa. Earlier in the year, the company made available the 2012 print edition of its GBR in a convenient, pocket-sized format. Like the print edition, the app - for iPhone(®), iPod(®) touch and iPad(® *) - provides an easy-to-use cross-reference guide for brand and generic product names, and in addition offers clinical support tools, including laboratory reference values, an interactive medical abbreviations converter, and functional calculators for common systems of weights and measures.
Mylan North America President Tony Mauro said: "We are pleased to offer Mylan's 2012 GBR to health care professionals in the U.S., including pharmacists, physicians and nurses, and chain and wholesale buyers. The GBR provides a comprehensive and up-to-date list of the generic and brand names for more than 2,000 separate oral and liquid dosage forms, as well as injectable and transdermal products. Mylan is committed to partnering with health care providers to optimize their time and together expand access to high quality medicine."
Mylan's printed GBR includes product portfolio sections under the Mylan Pharmaceuticals, Mylan Institutional and Mylan Specialty names and provides an easy-to-navigate, alphabetized reference source for many health care providers working in one space. The app offers all of the convenience of the printed edition on a mobile device, including content that is updated to keep the dataset current, a smart search function, easy navigation and interactive clinical support tools.
To request a free printed copy of Mylan's 2012 GBR, visit mylanpharms.com. To download Mylan's free GBR app, visit the App Store(sm**) from any iOS-supported device, including the iPhone, iPod touch and iPad.
Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com.
* iPhone, iPod touch, and iPad( )are registered trademarks of Apple Inc.
** App Store is the service mark of Apple Inc.
SOURCE Mylan Inc.
Mylan Inc.
CONTACT: Nina Devlin (Media), +1 724.514.1968; Kris King (Investors), +1 724.514.1813
Web Site: http://www.mylan.com